| Lizenz: Creative Commons Namensnennung 4.0 International (656kB) |
- URN zum Zitieren dieses Dokuments:
- urn:nbn:de:bvb:355-epub-382045
- DOI zum Zitieren dieses Dokuments:
- 10.5283/epub.38204
Zusammenfassung
Objective: The aim of this study was to evaluate the diagnostic performance of a multiparametric gadolinium ethoxybenzyl-diethylenetriaminepentaacetic acid (Gd-EOB-DTPA)-enhanced MRI examination for the estimation of liver dysfunction classified by the Model for End-Stage Liver Disease (MELD) score. Results: Liver dysfunction can be assessed by different methods. In a logistic regression ...
Nur für Besitzer und Autoren: Kontrollseite des Eintrags